Table 3 Comparison of self-efficacy and QoL-related indicators between groups across study periods using generalized estimating equation models.
Outcome variables, means ± SD | G0(n = 172) | G1(n = 188) | G2(n = 193) | G3(n = 194) | Group effecta | Group * Time interaction effect | |||
|---|---|---|---|---|---|---|---|---|---|
Wald χ2 | P-value | Wald χ2 | P-value | ||||||
Self-efficacy score | T0 | 8.05 ± 1.29 | 8.11 ± 1.38 | 8.13 ± 1.32 | 8.07 ± 1.61 | – | – | 9.267 | 0.413 |
T1 | 8.09 ± 1.29 | 8.31 ± 1.22 | 8.50 ± 1.32 | 8.62 ± 1.37 | – | – | |||
T2 | 8.23 ± 0.96 | 8.33 ± 1.07 | 8.47 ± 1.23 | 8.51 ± 1.31 | – | – | |||
T3 | 8.07 ± 1.01 | 8.30 ± 1.13 | 8.44 ± 1.39 | 8.55 ± 1.28 | – | – | |||
Time effectb | Wald χ2 | – | – | – | – | ||||
P-value | – | – | – | – | |||||
Health utility value | T0 | 0.96 ± 0.07 | 0.97 ± 0.07 | 0.97 ± 0.07 | 0.97 ± 0.06 | 1.273 | 0.736 | 16.957 | 0.049* |
T1 | 0.96 ± 0.07 | 0.96 ± 0.10 | 0.97 ± 0.09 | 0.99 ± 0.10 | 19.498 | < 0.001* | |||
T2 | 0.97 ± 0.07 | 0.97 ± 0.09 | 0.98 ± 0.07 | 0.98 ± 0.06 | 4.411 | 0.220 | |||
T3 | 0.97 ± 0.09 | 0.97 ± 0.10 | 0.99 ± 0.05 | 0.99 ± 0.07 | 12.573 | 0.006* | |||
Time effectb | Wald χ2 | 1.240 | 2.797 | 12.731 | 27.909 | ||||
P-value | 0.744 | 0.424 | 0.005* | < 0.001* | |||||
EQ-VAS score | T0 | 79.03 ± 13.59 | 80.27 ± 15.17 | 78.59 ± 18.30 | 78.19 ± 19.59 | – | – | 11.660 | 0.233 |
T1 | 79.50 ± 18.09 | 81.39 ± 13.54 | 83.83 ± 18.26 | 84.07 ± 18.69 | – | – | |||
T2 | 79.82 ± 18.20 | 81.29 ± 18.53 | 82.75 ± 11.49 | 83.49 ± 12.74 | – | – | |||
T3 | 80.55 ± 17.78 | 82.37 ± 12.32 | 83.07 ± 10.24 | 83.32 ± 12.35 | – | – | |||
Time effectb | Wald χ2 | – | – | – | – | ||||
P-value | – | – | – | – | |||||